The following guideline can be ordered through the address listed in the "Source/Publisher"-category.
In cases in which you can order through the Internet we have established a hyperlink.
Eudralex Volume 3 NOTE FOR GUIDANCE ON THE INVESTIGATION OF BIOAVAILABILITY AND BIOEQUIVALENCE CPMP/EWP/QWP/1401/98
It is the objective of this guidance to define, for products with a systemic effect, when
bioavailability or bioequivalence studies are necessary and to formulate requirements for their
design, conduct, and evaluation. The possibility of using in vitro instead of in vivo studies
with pharmacokinetic end points is also envisaged.